Elicio Therapeutics Inc. (ELTX)
undefined
undefined%
At close: undefined
5.07
1.60%
After-hours Dec 13, 2024, 03:59 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY13 FY12
Net Income -35.20M -28.21M -26.40M -15.71M -12.26M -20.02M 632.24K 307.30K
Depreciation & Amortization 1.17M 390.32K 251.45K 193.43K 108.37K 2.00K 460.34K 463.22K
Stock-Based Compensation 1.18M 579.00K 617.76K 304.47K 145.08K - - -
Other Working Capital -80.00K -607.35K 842.21K -2.66M 2.69M 2.46M 409.92K -403.39K
Other Non-Cash Items 209.00K 3.60M 667.05K 50.99K 18.00K 8.29M 1.58M 1.18M
Deferred Income Tax - 947.42K 52.96K - 1.95K - -118.00K -212.00K
Change in Working Capital -57.00K 516.74K 872.43K -1.54M 2.69M 3.09M 332.64K -74.98K
Operating Cash Flow -32.69M -22.18M -23.94M -16.70M -9.29M -8.02M 1.89M 1.07M
Capital Expenditures -66.00K -653.84K -525.36K -199.92K -489.10K - -17.57K -47.73K
Acquisitions - - - - - - - -
Purchase of Investments - - - - - - -50.00K -
Sales Maturities Of Investments - - - - - - - -
Other Investing Acitivies 34.00K - - - - - - -
Investing Cash Flow -32.00K -653.84K -525.36K -199.92K -489.10K - -67.58K -47.73K
Debt Repayment 10.00M - 14.03M - - 3.15M - -
Common Stock Repurchased -150.00K - - -36.00K -375.00K - - -
Dividend Paid - - - - - - - -
Other Financial Acitivies 21.76M 21.20M 5.26M 25.06M 12.97M - -1.17M -429.23K
Financial Cash Flow 38.61M 21.20M 19.39M 25.06M 6.29M 31.74M -1.17M -429.23K
Net Cash Flow 5.89M -1.63M -5.07M 8.16M -3.49M 23.45M 652.76K 588.23K
Free Cash Flow -32.76M -22.83M -24.46M -16.90M -9.78M -8.02M 1.87M 1.02M